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OBJECTIVE — This study examines the usefulness of childhood glucose homeostasis vari-
ables (glucose, insulin, and insulin resistance index [homeostasis model assessment of insulin
resistance {HOMA-IR}]) in predicting pre-diabetes and type 2 diabetes and related cardiometa-
bolic risk factors in adulthood.
RESEARCH DESIGN AND METHODS — This retrospective cohort study consisted of
normoglycemic (n  1,058), pre-diabetic (n  37), and type 2 diabetic (n  25) adults aged
19–39 years who were followed on average for 17 years since childhood.
RESULTS — At least 50% of the individuals who ranked highest (top quintile) in childhood
for glucose homeostasis variables maintained their high rank by being above the 60th percentile
in adulthood. In a multivariate model, the best predictors of adulthood glucose homeostasis
variables were the change in BMI Z score from childhood to adulthood and childhood BMI Z
score, followed by the corresponding childhood levels of glucose, insulin, and HOMA-IR. Fur-
ther, children in the top decile versus the rest for insulin and HOMA-IR were 2.85 and 2.55
times,respectively,morelikelytodeveloppre-diabetes;childreninthetopdecileversustherest
for glucose, insulin, and HOMA-IR were 3.28, 5.54, and 5.84 times, respectively, more likely to
developdiabetes,independentofchangeinBMIZscore,baselineBMIZscore,andtotal-to-HDL
cholesterolratio.Inaddition,childrenwithadverselevels(topquintileversustherest)ofglucose
homeostasis variables displayed signiﬁcantly higher prevalences of, among others, hyperglyce-
mia, hypertriglyceridemia, and metabolic syndrome.
CONCLUSIONS — Adverse levels of glucose homeostasis variables in childhood not only
persist into adulthood but also predict adult pre-diabetes and type 2 diabetes and relate to
cardiometabolic risk factors.
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D
iabetes has become one of the most
commonly prevalent chronic dis-
eases with related mortality in the
U.S. (1). There are 19 million people
with type 2 diabetes and another 54 mil-
lion people with impaired fasting glucose
or pre-diabetes in the country (2). It is
also widely recognized that diabetes is a
major contributor to adult cardiovascular
morbidityandmortalityandoftenaccom-
panies hypertensive renal disease (3).
Type 2 diabetes is preceded by a pre-
diabetic state linked to relative insulin re-
sistance associated with mild increases in
blood glucose levels, despite hyperinsu-
linemia (4). A number of studies have in-
dicated that hyperinsulinemia/insulin
resistance is associated with cardiometa-
bolic risk factors including obesity,
dyslipidemia, and hypertension, a con-
stellationofdisorderscharacteristicofthe
metabolic syndrome (5,6). Previous ﬁnd-
ings, including our own, have shown that
theelevationsininsulin(7,8)andglucose
(9,10) levels persist (track) over time in
children and adults alike. We have re-
ported that individuals with relatively
high/low fasting plasma insulin levels
tended to remain so 8 years later; and
signiﬁcant clustering of obesity, hyper-
tension, and dyslipidemia occurred pri-
marily among those with persistently ele-
vated levels (8). However, information is
scant regarding whether the adverse lev-
els of glucose homeostasis variables (glu-
cose, insulin, and insulin resistance
index) in childhood persist over time and
predict pre-diabetes and type 2 diabetes
and other cardiometabolic risk factors in
apparently healthy young adults. The
present analysis examines this aspect as
part of the Bogalusa Heart Study, a bira-
cial (black and white), community-based
investigation of the evolution of cardio-
vascular disease risk beginning in child-
hood (11).
RESEARCH DESIGN AND
METHODS — The retrospective study
cohort was derived from the two sets of
the cross-sectional surveys conducted in
the community (65% white and 35%
blacksubjects)ofBogalusa,Louisiana,in-
volving ﬁve cross-sectional surveys of
childrenduring1981–1994(n13,444;
40% black and 50% female) and three
cross-sectional surveys of adults during
1995–2000 who remained in the com-
munityandparticipatedinthestudy(n
3,640). Subjects (n  1,120; 36% black
and 60% female) who participated in
their childhood and adulthood and had
fasting blood samples on both examina-
tions were included in the study. At the
baseline examination, the children with a
history of the treatment of diabetes or
who had a fasting glucose level 100
mg/dl (5.6 mmol/l) were excluded. These
subjectswere4–18yearsofage(means
SD age 11.6  3.6 years) at baseline and
19–39 years of age at follow-up (mean 
SD age in adulthood was 28.3  5.1
years). With respect to age, race, sex,
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glucose, and insulin proﬁle, the baseline
childhood characteristics of the study co-
hort, which represented 8% of the origi-
nal ascertained childhood population,
were similar to the characteristics of the
subjects who did not participate in the
follow-up survey as adults (data not
shown).
According to the American Diabetes
Association criteria (12), adult subjects
were classiﬁed as normoglycemic (n 
1,058) if they had a fasting glucose level
100 mg/dl (5.6 mmol/l), pre-diabetic
(n37)iftheyhadafastingglucoselevel
between 100 and 125 mg/dl (5.6–6.9
mmol/l),anddiabetic(n25)iftheyhad
a fasting glucose level 126 mg/dl (7
mmol/l) or were taking medication for
diabetes. Informed consent was ob-
tained from all participants, and the
study was approved by the institutional
review board of the Tulane University
Health Sciences Center.
General examination
Standardized protocols were used by
trained examiners across all surveys (13).
Participants were instructed to fast for
12 h before the venipuncture, and com-
pliance was ascertained by an interview
on the day of examination. Information
on personal health history (e.g., hyper-
tension, dyslipidemia, or diabetes and
medical treatment for these conditions)
was obtained by questionnaires. Anthro-
pometric and blood pressure measure-
ments were made in replicate and mean
values were used. BMI (in kg/m
2 
weightinkilogramsdividedbythesquare
ofheightinmeters)wasusedasameasure
of overall adiposity; waist circumference
wasusedasanindicatorofabdominalvis-
ceral fat. BMI Z scores for childhood were
calculated from the 2000 Centers for Dis-
ease Control and Prevention (CDC)
growth charts to account for the differ-
ences in BMIs by sex and age (14). These
growth charts express the BMIs of chil-
dren in the current study relative to their
sex- and age-matched peers in the U.S.
between 1963 and 1980; BMIs of 5 year
olds in the CDC growth charts also in-
clude data from 1988 to 1994. BMIs for
adulthood were standardized based on
age- and sex-speciﬁc means and SDs. The
calculated Z scores are termed “BMI Z
score” in the current analyses. Right up-
per-arm length and circumference were
used to select the cuff size for blood pres-
sure measurements with mercury sphyg-
momanometers. Two randomly assigned
nurses measured blood pressure (three
replicates each) while subjects were in a
relaxed, sitting position. Systolic and dia-
stolic blood pressures were recorded at
the ﬁrst and fourth (children) or ﬁfth
(adults) Korotkoff, respectively. Mean ar-
terial pressure (MAP), calculated as dia-
stolicbloodpressureplusone-thirdpulse
pressure, was used in the analysis.
Laboratory analyses
Cholesterol and triglyceride levels were
initially measured using chemical proce-
dures on a Technicon Autoanalyzer II
(TechniconInstruments)accordingtothe
laboratory manual of the lipid research
clinics program. Later, these variables
were determined by enzymatic proce-
dures on the Abbott VP Instrument (Ab-
bott Laboratories) between 1987 and
1996 and on the Hitachi 902 Automatic
Analyzer (Roche Diagnostics) afterward.
Both chemical and enzymatic procedures
met the performance requirements of
the lipid standardization program of the
CDC, which has routinely monitored the
precision and accuracy of cholesterol,
triglycerides, and HDL cholesterol mea-
surements since the beginning of this
study. Serum lipoprotein cholesterol lev-
els were analyzed by using a combination
of heparin-calcium precipitation and aga-
r–agarose gel electrophoresis procedures
(15). The intraclass correlation coefﬁ-
cients between the blind duplicate (10%
random sample) values ranged from 0.86
to 0.98 for HDL cholesterol, 0.86 to 0.98
for LDL cholesterol, and 0.88 to 0.99 for
triglycerides.
From 1976 to 1991, plasma glucose
was measured initially by a glucose oxi-
dasemethodusingaBeckmanglucosean-
alyzer (Beckman Instruments). Since
then, it has been measured enzymatically
as part of a multichemistry (SMA20) pro-
ﬁle.Plasmaimmunoreactiveinsulinlevels
were measured by a commercial radioim-
munoassay kit (Phadebas, Pharmacia Di-
agnostics). The intraclass correlation
coefﬁcients between blind duplicate val-
ues ranged from 0.94 to 0.98 for insulin
and 0.86 to 0.98 for glucose. In addition,
an index of insulin resistance was calcu-
lated according to the homeostasis model
assessment (HOMA) formula: HOMA of
insulin resistance (HOMA-IR)  (insulin
[U/ml]  glucose [mmol/l]/22.5).
Metabolic syndrome risk factors in
adults were identiﬁed if subjects were
centrally obese (waist circumference
102cmformalesubjectsor88cmfor
female subjects), were dyslipidemic (LDL
cholesterol 160 mg/dl [4.14 mmol/l],
triglycerides 150 mg/dl [2.26 mmol/l],
HDL cholesterol 40 mg/dl [1.03
mmol/l] for male or 50 mg/dl [1.29
mmol/l] for female subjects, or on medi-
cation for dyslipidemia), were hypergly-
cemic (fasting glucose 100 mg/dl [5.6
mmol/l] or on treatment for diabetes), or
were hypertensive (systolic blood pres-
sure130mmHgordiastolicbloodpres-
sure 85 mmHg or on antihypertensive
medication) (16). Metabolic syndrome
was deﬁned as coexistence of three or
more of the above risk factors (16).
Statistical analysis
All of the statistical analyses were per-
formed with SAS version 9.1 (SAS Insti-
tute). Continuous variables were tested
for normality using a Kolmogorov-
Smirnov test. Values of triglycerides, glu-
cose, insulin, and HOMA-IR variables
usedintheanalyseswerelog-transformed
to improve normality. To evaluate the
persistence or tracking of elevated levels
of glucose, insulin, and HOMA index
from childhood to adulthood, the base-
line (childhood) age-, race-, and sex-
speciﬁc top quintile for each of these
variables was used as a cutoff point to
classify children as having abnormal glu-
cose homeostasis variables and to exam-
ine the distribution of such children
among the corresponding adulthood
quintiles 17 years later.
Models assessing the independent re-
lations between childhood cardiometa-
bolic risk factor variables and follow-up
(adulthood) levels of glucose, insulin, or
HOMA-IR were constructed using a step-
wisemultiplelinearregression.Thechild-
hood independent variables initially
included in these models were age, race,
sex, BMI Z score, BMI Z score change
from childhood to adulthood, MAP, ratio
of total cholesterol to HDL cholesterol, as
well as glucose (for model 1), insulin (for
model 2), and HOMA-IR (for model 3).
Since waist circumference in childhood
was not measured, BMI Z score values
were used as a childhood measure of obe-
sity. The ratio of total to HDL cholesterol
was chosen as a measure of dyslipidemia
becauseitisamarkerofinsulinresistance
characteristic of the metabolic syndrome.
A stepwise logistic regression analysis
including childhood age, race, sex, BMI Z
score, BMI Z score change over time,
MAP, and total-to-HDL cholesterol ratio
wasthenusedtodeterminetheoddsratio
and 95% CI of developing pre-diabetes
and diabetes in adulthood on the basis of
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rest) of glucose and insulin (model 1) and
HOMA-IR (model 2). Collinearity was
checked in the ﬁxed model. To assess the
overallﬁtofthelogisticregressionmodel,
a Hosmer-Lemeshow goodness-of-ﬁt test
was performed. Because there was no in-
teraction effect between childhood race
(or sex) and glucose (or insulin and
HOMA-IR) levels, the race-sex groups
were combined to increase statistical
power and to simplify the presentation.
Since the prevalence of both pre-diabetes
and diabetes in the study cohort was low
(3.5%) and the alternate analysis using
the Cox proportional hazard model gave
essentially identical results, only the re-
sults of logistic regression analysis esti-
mating the relative risk of diabetes status
are presented.
Finally,theprevalenceofcardiometa-
bolic risk factors in adulthood was exam-
ined according to childhood levels (top
quintile versus the rest, speciﬁc for age,
race, and sex) of glucose and insulin.
Signiﬁcant differences in the prevalence
of the metabolic syndrome and its car-
diometabolic risk factors in adulthood
by childhood glucose, insulin, and
HOMA-IR status were tested by the
Pearson’s 
2 test.
RESULTS— The persistence (track-
ing) of levels of glucose homeostasis vari-
ables (fasting glucose, insulin, and
HOMA-IR) from childhood to adulthood
was examined in terms of persistence of
ranking in highest quintiles of the distri-
butionovera17-yearperiod.Ifthereisno
persistence, 20% of those in a given quin-
tile at baseline would persist in that rank-
ingatthefollow-upassessmentbychance
alone. As shown in Fig. 1, 32.1% of in-
dividuals who ranked highest (in the top
quintile) with respect to glucose in child-
hood also did so in adulthood; another
22.5% remained in the next highest
(fourth) quintile. In other words, 54.6%
of individuals who ranked highest in
childhood tended to maintain their high
ranks by being above the 60th percentile
in adulthood. Insulin and HOMA-IR lev-
els showed similar trends for tracking
over time. Further, these individuals
(trackers) who maintained their high
ranks by being above the 60th percentile
in adulthood with respect to glucose, in-
sulin, and HOMA-IR, compared with the
nontracker group (individuals in top
quintile at baseline and below the 60th
percentile in adulthood), displayed con-
sistently higher BMI Z score at baseline
and BMI Z score change after 17-year fol-
low-up(P0.05),afteradjustingforage,
race, and sex at baseline; no consistent
trend was observed in other cardiometa-
bolic variables (data not shown). With
respect to tracking in the lowest quin-
tiles from childhood to adulthood, the
trends were essentially the same (data
not shown).
As shown in Table 1, based on a step-
wise multivariate regression analysis,
childhood levels of glucose (model 1),
insulin (model 2), and HOMA-IR
(model 3) were independent predictors
of corresponding follow-up adulthood
levels17yearslater.However,asshown
by the standardized regression coefﬁ-
cients, the best predictors for adult glu-
Figure 1—Tracking of glucose, insulin, and HOMA index over a 17-year period in young adults.
The degree of tracking was evaluated in terms of distribution by adulthood quintiles at follow-up
of subjects who were in the extreme top quintile speciﬁc for age, race, and sex at baseline in
childhood. The percentage on the vertical axis denotes the proportion of subjects at baseline in
childhood remaining in each quintile at follow-up in adulthood.
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the change of BMI Z score from child-
hood to adulthood and baseline BMI Z
score, in that order. The next best pre-
dictors for all these variables were the
corresponding childhood level, fol-
lowed by male sex (for glucose ad insu-
lin), age (for glucose), and total-to-HDL
cholesterol ratio (for glucose, insulin,
and HOMA-IR), in that order. Over-
all, these variables accounted for
12.5,45.4,and43.9%ofthevariancein
glucose, insulin, and HOMA-IR,
respectively.
As shown in Table 2, among the
childhood glucose homeostasis variables,
insulin and HOMA-IR (top decile versus
the rest) showed an odds ratio of 2.85
(P  0.05) and 2.55 (P  0.05), respec-
tively, for developing pre-diabetes after
17 years. In addition, age, baseline BMI Z
score, BMI Z score change over time, and
total-to-HDL cholesterol ratio showed
odds ratios of 1.14, 1.44, 1.85, and
1.05, respectively, for developing pre-
diabetes (P  0.05). With respect to de-
veloping diabetes, the odds ratios were
3.28 (P  0.05) for glucose, 5.54 (P 
0.0001) for insulin, and 5.84 for
HOMA-IR (P  0.0001); neither BMI Z
score nor BMI Z score change over time
predictedthedevelopmentofoverttype2
diabetes. Further, alternate logistic re-
gression models including age, race, sex,
BMIZscore,andBMIZscorechangeover
time, along with either childhood glucose
and insulin (model 1) or HOMA-IR
(model 2), showed glucose homeostasis
variables, BMI Z score, and BMI Z score
change over time as signiﬁcant predictors
of adult pre-diabetes and diabetes (P 
0.05). P values of goodness-of-ﬁt test for
all models were 0.20 (data not shown).
On the basis of glucose homeostasis
variable levels (top quintile versus the
rest), children were classiﬁed into low-
risk versus high-risk group and the
prevalence rates of obesity, hyper-
tension, dyslipidemia, hyperglycemia,
hyperinsulinemia, and metabolic syn-
drome in adulthood after 17 years of fol-
low-up were compared between the two
groups (supplementary Table 1 of the on-
line appendix [available at http://
care.diabetesjournals.org/cgi/content/
full/dc09-1635/DC1]). The prevalence of
adulthood metabolic syndrome and its
variables in the high-risk versus low-risk
group was signiﬁcantly greater with re-
spect to hyperglycemia, hypertriglyceri-
demia (marginal signiﬁcant in childhood
insulin group), hypertension (except
childhood glucose group), obesity (ex-
cept childhood glucose group), low HDL
cholesterol (except childhood glucose
group), high LDL cholesterol (childhood
glucose group only), and metabolic
syndrome.
CONCLUSIONS — This communi-
ty-basedstudydemonstratesthatelevated
levels of glucose, insulin, and insulin re-
sistance index (HOMA-IR) in childhood
trackandpersistinrankingovera17-year
period. Childhood levels relate indepen-
dently to corresponding adulthood levels
and predict pre-diabetes (except child-
hood glucose) and diabetes conditions in
adulthood, independent of age, race, sex,
change in BMI Z score over time, child-
hood BMI Z score, MAP, and total-to-
HDL cholesterol ratio. In addition,
childhood high- versus low-risk status
(top quintile versus the rest) with respect
to glucose homeostasis variables was as-
sociatedwithincreasedprevalencesofthe
metabolic syndrome and its component
cardiometabolicriskfactors.Ofparticular
interest, childhood glucose levels clini-
cally considered within the normal range
Table 1—Childhood predictors of follow-up levels of glucose, insulin, and HOMA-IR in young
adults after 17 years
Glucose
(model 1)
Insulin
(model 2)
HOMA-IR
(model 3)
Childhood predictor variable* 			
Age 0.11†
Sex (male  female) 0.10† 0.08†
BMI Z score at baseline 0.25‡ 0.61‡ 0.60‡
BMI Z score change over time 0.25‡ 0.63‡ 0.62‡
Total-to-HDL cholesterol ratio 0.06§ 0.06§ 0.07
Glucose 0.16‡
Insulin 0.10†
HOMA-IR 0.11‡
Model R
2 (%) 12.5 45.4 43.9
	isthestandardizedregressioncoefﬁcient.*Stepwiseregressionmodelincludesage,race,sex,baselineBMI
Z score, BMI Z score change over time, MAP, total-to-HDL cholesterol ratio, as well as baseline childhood
glucoseandinsulin(models1and2,respectively)andHOMA-IR(model3).†P0.001;‡P0.0001;§P
0.05; P  0.01.
Table 2—Odds ratios (95% CIs) for developing pre-diabetes and diabetes in adulthood on the
basis of childhood levels of glucose, insulin, and HOMA-IR
Childhood deciles (top
versus the rest)* Pre-diabetes I P Diabetes P
Model 1
Age 1.14 (1.03–1.26) 0.01
BMI Z score at baseline 1.43 (1.04–1.96) 0.05
BMI Z score change
over time 1.84 (1.21–2.78) 0.01
Total-to-HDL
cholesterol ratio 1.05 (1.00–1.09) 0.05
Glucose 3.28 (1.29–8.33) 0.05
Insulin 2.85 (1.22–6.66) 0.05 5.54 (2.33–13.19) 0.0001
Model 2
Age 1.14 (1.03–1.26) 0.05
BMI Z score at baseline 1.44 (1.05–1.98) 0.05
BMI Z score change
over time 1.85 (1.23–2.79) 0.01
Total-to-HDL
cholesterol ratio 1.05 (1.01–1.09) 0.05
HOMA-IR 2.55 (1.10–5.95) 0.05 5.84 (2.51–13.60) 0.0001
*Stepwise logistic regression model includes age, race, sex, baseline BMI Z score, BMI Z score change over
time, MAP, total-to-HDL cholesterol ratio, as well as baseline childhood glucose and insulin (top decile
versus the rest) for model 1 and HOMA-IR (top decile versus the rest) for model 2.
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abetes.
The concept of tracking of cardiom-
etabolic risk factors over time is well rec-
ognized. The current ﬁndings showing
thepersistenceofadverselevelsofglucose
homeostasis variables since childhood
(7–10), and related predictability of adult
pre-diabetes and diabetes conditions, are
in agreement with previous reports
(6,17,18). Bao et al. (8) have demon-
strated that the individuals with relatively
high/low insulin levels trended to retain
such levels over an 8-year follow-up. Of
thosewhohadinsulinlevelsrankedinthe
top quartile at baseline, 40% remained so
after 8 years (8). Elevations in fasting
plasma glucose within the normoglyce-
mic range indeed may track from child-
hood to adulthood and reﬂect the
progression from normal glucose toler-
ance before the onset of impaired glucose
regulation as a continuous process in the
development of diabetes (10,18,19).
Of note, gain in adiposity (BMI), a
modiﬁable risk factor, from childhood to
adulthood along with childhood adipos-
ity were the best predictors of the adult
glucose homeostasis variables in this
study. Because obesity is pathologically
linked to insulin resistance/hyperinsulin-
emia, it plays a crucial role as an initiating
factorinthedevelopmentofdysglycemia.
This is consistent with earlier observa-
tions showing temporal associations be-
tween the degree of baseline adiposity
and the incidence of hyperinsulinemia
(20) or metabolic syndrome (21), inde-
pendently of baseline insulin levels.
Studies (6,9,18) have also shown base-
line obesity to be an independent risk
factor for type 2 diabetes.
The observational nature of the cur-
rent study can not address the issue of
causality but only suggests putative
mechanisms for the observed relation-
ships. Intra-abdominal and intramyocel-
lular lipid accumulation along with
adipocyte-derived cytokines have been
involvedinthedevelopmentofinsulinre-
sistance and the attendant type 2 diabetes
(22). It is also apparent from the present
study that children with top quintile
(high risk) of glucose, insulin, and
HOMA-IR levels displayed increased
prevalence of metabolic syndrome and
are associated with type 2 diabetes. As
mentioned earlier, excess adiposity, espe-
cially visceral fat, may be the initiating
factor in the observed adverse relation-
ships (21). Excess fat and related insulin
resistance/hyperinsulinemia increase tri-
glyceride (VLDLs) levels as a result of ab-
normal fatty acid metabolism and excess
hepatic triglyceride synthesis and/or low
clearance of triglycerides from the circu-
lation (23). In turn, increases in LDL cho-
lesterol and decreases in HDL cholesterol
levels ensue (24).
With respect to blood pressure, hy-
perinsulinemia could relate to raises in
levelsby1)increasingrenalsodiumreten-
tion, 2) stimulating the sympathetic ner-
voussystem,3)disturbingcellmembrane
calcium transport, and 4) increasing the
smooth muscle cell proliferation (5,25).
Alternatively, excess adiposity, per se, in-
creases blood pressure by adversely alter-
ing, among others, intravascular volume,
cardiacoutput,renalpressurenatriuresis,
and the adipose renin-angiotensin-
aldosterone system (25). Taken together,
itappearsthatexcesslevelsofglucoseho-
meostasis variables within the normogly-
cemic range even in childhood is a
biomarker of risk for developing adverse
cardiometabolic conditions including di-
abetesandsubtleabnormalitiesofthecar-
diovascular system.
The present study has certain limita-
tions in that it lacks direct assessments of
postchallenge glucose, in vivo insulin ac-
tionandsecretion,glycosylatedhemoglo-
bin, and body fat mass and distribution.
Instead, we used well-established simple
surrogate measures of glucose homeosta-
sis that are applicable to population stud-
ies. The fasting status for metabolic
variables including glucose was based on
self-report. However, it should be men-
tioned that nonsystematic misclassiﬁca-
tion of self-reports would actually tend to
underestimate the outcome. Further, the
current ﬁndings should be viewed with
caution in view of the modest number of
events, especially diabetes.
In summary, the present ﬁndings in-
dicate the importance of even moderately
elevated levels of childhood glucose ho-
meostasis variables (glucose, insulin, and
HOMA-IR)consideredwithinthenormo-
glycemicrangeintermsofpredictingpre-
diabetes, diabetes, and metabolic
syndrome and its cardiometabolic risk
factors in apparently healthy young
adults, with obesity and the change of
obesity levels over time being the major
contributors. Additional longitudinal
population-based studies are obviously
needed to validate the current ﬁndings
and to develop the common glucose ho-
meostasis variable cutoff values for type 2
diabetes and other cardiometabolic risk
assessment and intervention in pediatric
population.
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